MedPath

A prospective, natural history study to assess the occurrence of HPA-1a alloimmunization in women identified at higher risk for Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Recruiting
Conditions
Blood platelet shortage
NAIT
10035534
10028920
Registration Number
NL-OMON54467
Lead Sponsor
Rallybio
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
2000
Inclusion Criteria

Pregnant women (>= 18 years of age) who have provided informed consent for the
study.

Exclusion Criteria

Prior history of FNAIT

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary objective:<br /><br><br /><br>To inform the frequency of women at higher FNAIT risk among pregnant women of<br /><br>different racial and ethnic characteristics who present for<br /><br>pre-natal care.<br /><br><br /><br>Primary outcome:<br /><br><br /><br>The number of participants that are determined to be at higher FNAIT risk<br /><br>compared to the total number of pregnant women assessed for higher<br /><br>FNAIT risk, with attention to self-characterized race and ethnicity.</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath